Asia Pacific Platelet Rich Plasma Tube Market

The Asia Pacific platelet rich plasma tube market is expected to grow from US$ 78.59 million in 2022 to US$ 213.81 million by 2028. It is estimated to record a CAGR of 18.2% from 2022 to 2028.

Incorporation of Platelet-Rich Plasma in Regenerative Medicine to Provide Lucrative Opportunities for the Asia Pacific Platelet-Rich Plasma (PRP) Tube Market in Coming Years

Regenerative medicine is a major part of the rapidly emerging biomedical research that involves the development of new therapeutic strategies, resulting in significant medical advancements. Peripheral nerve injuries (PNIs) have become common, as a large number of cases are reported every year, and the slow regeneration process post these injuries leads to loss of nerve functions. Considering this, research on the mechanism of peripheral nerve regeneration has flourished worldwide, and scholars are seeking different methods to enhance the regeneration process. PRP therapy incorporates mainstream technologies for repairing and rejuvenating the tissues damaged due to injuries or chronic diseases. Evidence has shown that micro-needling and topical application, along with PRP, improves collagen production and skin tightening during vampire facials. According to the "Combined micro needling with topical application of platelet-rich plasma versus micro-needling alone in the treatment of stria distensae," a report published in 2020, MN-PRP was associated with excellent recovery of Striae distensae (SD) skin lesions, more significant deposition of collagen and elastic fibers, increased proliferative activity in epidermis, and decreased caspase-3 protein expression values in epidermis. PRP application has also been explored in the treatment of skin pigmentation disorders and acne scars. In hair transplants, PRP can bind to growth factors and boost the proliferation of human derma papilla cells, leading to the formation and maintenance of hair follicles. PRP contains platelets in a concentrated form. A high concentration of platelets can release various growth factors after activation, thereby promoting the proliferation and differentiation of tissue cells as well as accelerating the tissue regeneration process. PRP therapy is also utilized for musculoskeletal regeneration to heal sports and orthopedic-associated injuries. According to the National Institute of Health (NIH) report, PRP-based treatments have proved to be beneficial in healing acute hamstring-associated injuries. Thus, PRP injections are gaining popularity in regenerative medicine owing to their ability to accelerate tissue regeneration, which is likely to provide lucrative opportunities for the Asia Pacific platelet-rich plasma (PRP) tube market in the coming years.

Asia Pacific Platelet Rich Plasma Tube Market Overview

Plastic surgery is a booming business in China. According to the International Society of Aesthetic Plastic Surgery’s 2019 global statistics report, China ranks among the top three countries with the highest number of practicing plastic surgeons. It is also the most frequently cited countries for medical tourism. With capital pouring in, the medical aesthetic industry in the country has developed a clear and complete industrial chain composed of upstream manufacturers, medical aesthetic service providers, and medical aesthetic users. Skin rejuvenation with PRP is usually considered for various body parts, such as the face, neck, décolleté, hands, and inner sides of the legs and arms. A quick structuring of the skin is possible immediately after applications such as laser and peeling. The most striking feature of the PRP method is that it offers completely natural rejuvenation without adding foreign substances or drugs to the body. The DermaPrecise Injector is an electronic injection system designed to offer new levels of control over any injection into the dermal and subcutaneous layers for which precision of depth, dose, and delivery matters. PRP tubes are now becoming an indispensable tool in cutaneous and aesthetic surgery, which is likely to boost their demand in Asia Pacific in the coming years.

Asia Pacific Platelet Rich Plasma Tube Market Revenue and Forecast to 2028 (US$ Million)

Asia Pacific Platelet Rich Plasma Tube Market Segmentation 

The Asia Pacific platelet rich plasma tube market is segmented on the basis of usage, volume, end user, and country.

Based on usage, the Asia Pacific platelet rich plasma tube market is segmented into skin rejuvenation, hair restoration, orthopedics, surgical oncology, gynecology, and others. In 2022, the others segment accounted for the largest market share. The skin rejuvenation segment is further subsegmented into scars, skin aging, acne, skin ulcers, and others.

By volume, the Asia Pacific platelet rich plasma tube market is segmented into less than 5 ml, 6 ml to 10 ml, and more than 10 ml. In 2022, the more than 10 ml segment accounted for the largest market share.

The Asia Pacific platelet rich plasma tube market, in terms of end user, is segmented into MedSpas, dermatology offices, hospitals and healthcare practices, tricologist practices, and others. In 2022, the hospitals and healthcare practice segment held the largest share of the market.

Based on country, the Asia Pacific platelet rich plasma tube market is segmented into China, India, Japan, Australia, South Korea, and the Rest of Asia Pacific. In 2022, China segment registered a largest share in the Asia Pacific platelet rich plasma tube market.

AdvaCare Pharma USA LLC; ADVIN HEALTH CARE; BIO-X; Henso Medical (Hangzhou) Co Ltd; Lingen Precision Medical Products Co Ltd; Manso Medical Co Ltd; and PROMED SOLUTIONS, are the leading companies operating in the Asia Pacific platelet rich plasma tube market.

Asia Pacific Platelet Rich Plasma Tube Market Strategic Insights

Asia Pacific Platelet Rich Plasma Tube Market Segmentation Analysis

Asia Pacific Platelet Rich Plasma Tube Market Report Highlights

Asia Pacific Platelet Rich Plasma Tube Report Scope

Asia Pacific Platelet Rich Plasma Tube Market Country and Regional Insights